Lonza Group AG ADR (LZAGY)

Currency in USD
69.09
-0.03(-0.04%)
Closed·
Earnings results expected in 12 days
LZAGY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
68.5769.28
52 wk Range
58.5374.36
Key Statistics
Prev. Close
69.09
Open
69.05
Day's Range
68.57-69.28
52 wk Range
58.53-74.36
Volume
32.82K
Average Volume (3m)
44.6K
1-Year Change
1.6478%
Book Value / Share
143.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LZAGY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
79.23
Upside
+14.67%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Lonza Group AG ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 79.23
(+14.67% Upside)

Earnings

Latest Release
Jul 22, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 15.47%
Dividend Yield
0.57%
Industry Median 0.75%
Annualized payout
0.40
Paid unevenly
5-Years Growth
+10.76%
Growth Streak

LZAGY Income Statement

Compare LZAGY to Peers and Sector

Metrics to compare
LZAGY
Peers
Sector
Relationship
P/E Ratio
37.3x37.4x−0.3x
PEG Ratio
−0.32−1.310.00
Price/Book
5.0x4.8x2.6x
Price / LTM Sales
5.9x4.6x3.0x
Upside (Analyst Target)
14.6%4.7%57.9%
Fair Value Upside
Unlock1.1%7.6%Unlock

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
28.69M41.08%1.99B
Other Institutional Investors
-2.00M-2.87%-139.02M
Public Companies & Retail Investors
43.16M61.79%2.99B
Total
69.84M100.00%4.84B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
UBS Asset Management AG5.64%3,939,871273,191
BlackRock, Inc.5.21%3,637,386252,216

People Also Watch

87.01
ABVX
-1.37%
49.90
STMPA
-4.04%
124.3000
PRY
-4.68%
5.85
ALVO
-4.72%
141.650
HEIG
-3.61%

FAQ

What Is the Lonza Group AG ADR (LZAGY) Stock Price Today?

The Lonza Group AG ADR stock price today is 69.09 USD.

What Stock Exchange Does Lonza Group AG ADR Trade On?

Lonza Group AG ADR is listed and trades on the OTC Markets.

What Is the Stock Symbol for Lonza Group AG ADR?

The stock symbol for Lonza Group AG ADR is "LZAGY."

Does Lonza Group AG ADR Pay Dividends? What’s The Current Dividend Yield?

The Lonza Group AG ADR dividend yield is 0.57%.

What Is the Lonza Group AG ADR Market Cap?

As of today, Lonza Group AG ADR market cap is 48.38B USD.

What Is Lonza Group AG ADR's Earnings Per Share (TTM)?

The Lonza Group AG ADR EPS (TTM) is 15.47.

When Is the Next Lonza Group AG ADR Earnings Date?

Lonza Group AG ADR will release its next earnings report on Oct 20, 2026.

From a Technical Analysis Perspective, Is LZAGY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Lonza Group AG ADR Stock Split?

Lonza Group AG ADR has split 0 times.

How Many Employees Does Lonza Group AG ADR Have?

Lonza Group AG ADR has 20141 employees.

What is the current trading status of Lonza Group AG ADR (LZAGY)?

As of Oct 08, 2026, Lonza Group AG ADR (LZAGY) is trading at a price of 69.09 USD, with a previous close of 69.09 USD. The stock has fluctuated within a day range of 68.57 USD to 69.28 USD, while its 52-week range spans from 58.53 USD to 74.36 USD.

What Is Lonza Group AG ADR (LZAGY) Price Target According to Analysts?

The average 12-month price target for Lonza Group AG ADR is 79.23 USD, with a high estimate of 85.26208468 USD and a low estimate of 75.54036224 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +14.67% Upside potential.

What Is the LZAGY Premarket Price?

LZAGY's last pre-market stock price is 69.34 USD. The pre-market share volume is 690.00, and the stock has decreased by 0.22, or 0.32%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.